Skip to main content
Fig. 1. | Allergy, Asthma & Clinical Immunology

Fig. 1.

From: Successful treatment of refractory status asthmaticus with omalizumab: a case report

Fig. 1.

ECMO and ventilation parameters. Arrows show ECMO initiation on day 1 and omalizumab administration on day 7. Tidal volume and minute ventilation significantly improved within 24 h after omalizumab administration. ECMO was stopped on day 9 and the patient was extubated on day 11. ECMO, extracorporeal membrane oxygenation; Ppeak, peak inspiratory pressure; Vte expiratory tidal volume

Back to article page